DENALI THERAPEUTICS INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 15.43 USD | +3.14% |
|
-3.56% | -28.10% |
| Apr. 09 | UBS Adjusts Denali Therapeutics Price Target to $32 From $70, Maintains Buy Rating | MT |
| Apr. 03 | Denali Therapeutics Insider Sold Shares Worth $1,896,250, According to a Recent SEC Filing | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Bearish |
| Resistance | 18.42 | 19.44 | 20.93 |
| Spread/Res. | -16.23% | -20.63% | -26.28% |
| Spread/Supp. | +3.14% | +3.14% | +7.15% |
| Support | 14.96 | 14.96 | 14.40 |
Technical Rankings Surperformance
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- DNLI Stock
- Charts Denali Therapeutics Inc.
